Viewing Study NCT01889433


Ignite Creation Date: 2025-12-25 @ 2:41 AM
Ignite Modification Date: 2026-03-04 @ 11:47 AM
Study NCT ID: NCT01889433
Status: COMPLETED
Last Update Posted: 2018-07-16
First Post: 2013-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C
Sponsor: Biocad
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module